Showing results (301-310 of 429) with videos related to

Sort By:
Pageof 43
Plos One|September 19, 2025
Molecular basis for the activation of the bitter taste receptor TAS2R14 by RitonavirJiao Wen, Xinyi Ma, Xinyi Zhou, et al.
Breast Cancer Research and Treatment|August 24, 2010
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
Oncotarget|June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationMonica Faronato, Van T M Nguyen, Darren K Patten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
The Journal of Biological Chemistry|November 24, 2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell lineRana Varshochi, Faezah Halim, Andrew Sunters, et al.
Nanoscale|January 17, 2019
Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancementIoannis G Theodorou, Pakatip Ruenraroengsak, Daniel A Gonzalez-Carter, et al.
Molecular Cancer Therapeutics|April 8, 2010
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Nature Communications|September 4, 2019
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapySung Pil Hong, Thalia E Chan, Ylenia Lombardo, et al.
Pageof 43